Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 |
filingDate |
2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9050ee69002dd7b4c8a8b0825d016cac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f9df09fb54817515c059b05cc36d62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd89739cdda496a23d16600f8f0974f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a861ef15b8014ccad2279a882a723f97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428512b9b8c26e9b5c3eb3a196d2c027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d0e62ed0278ff3ab6d67962333c08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4afac31615ee56c98315a73e1117c9a1 |
publicationDate |
2009-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7598281-B2 |
titleOfInvention |
Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes |
abstract |
The present invention comprises compounds and compositions for the treatment of metabolic disorders and more particularly, those insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistence and the like comprising acetic acid derivatives with arylcycloalkyl-substituted alkanoic acid derivatives and their salts. Known as peroxisome proliferator-activated receptors (PPAR) agonists/antagonists, the invention relates to compounds of the formula I n nwherein the various substituent R-groups are more specifically defined herein. |
priorityDate |
2004-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |